Get the Stockscreener App
73.00
0.72%
0.52
After Hours:
72.50
-0.50
-0.68%
Insmed Inc stock is traded at $73.00, with a volume of 1.77M.
It is up +0.72% in the last 24 hours and down -4.54% over the past month.
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
See More
Previous Close:
$72.48
Open:
$72.63
24h Volume:
1.77M
Relative Volume:
0.82
Market Cap:
$12.52B
Revenue:
$315.49M
Net Income/Loss:
$-746.89M
P/E Ratio:
-13.85
EPS:
-5.27
Net Cash Flow:
$-588.55M
1W Performance:
+1.64%
1M Performance:
-4.54%
6M Performance:
+169.07%
1Y Performance:
+189.11%
1-Day Range:
$71.65
$74.19
1-Week Range:
$70.00
$74.19
52-Week Range:
$21.92
$80.53
Insmed Inc Stock (INSM) Company Profile
Name
Insmed Inc
Sector
Industry
Phone
908-977-9900
Address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Initiated | Wolfe Research | Outperform |
| Dec-08-23 | Initiated | Wells Fargo | Overweight |
| Nov-20-23 | Resumed | JP Morgan | Overweight |
| Jul-26-23 | Initiated | Guggenheim | Buy |
| Dec-09-22 | Initiated | Mizuho | Buy |
| Dec-07-22 | Initiated | Barclays | Overweight |
| Nov-18-22 | Initiated | BofA Securities | Buy |
| Apr-27-22 | Initiated | Goldman | Buy |
| Dec-06-21 | Initiated | JP Morgan | Overweight |
| Oct-19-21 | Resumed | Monness Crespi & Hardt | Buy |
| Oct-19-21 | Resumed | Morgan Stanley | Overweight |
| Oct-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Oct-12-20 | Resumed | Stifel | Buy |
| Sep-03-19 | Initiated | Goldman | Buy |
| Apr-09-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-15-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jan-17-19 | Upgrade | Goldman | Neutral → Buy |
| Jan-02-19 | Initiated | Canaccord Genuity | Buy |
| Aug-06-18 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jul-23-18 | Initiated | Goldman | Neutral |
| Apr-23-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-21-18 | Initiated | Morgan Stanley | Overweight |
| Jan-18-18 | Initiated | Credit Suisse | Neutral |
| Sep-05-17 | Reiterated | Evercore ISI | Outperform |
| Aug-17-17 | Initiated | Evercore ISI | Outperform |
| Jul-11-17 | Initiated | Robert W. Baird | Outperform |
| Mar-15-16 | Initiated | Stifel | Buy |
| Nov-09-15 | Downgrade | UBS | Buy → Neutral |
| Oct-06-15 | Reiterated | H.C. Wainwright | Buy |
| Jun-09-15 | Initiated | Citigroup | Neutral |
| Mar-26-14 | Reiterated | HC Wainwright | Buy |
View All
Insmed Inc Stock (INSM) Latest News
Insmed's SWOT analysis: stock poised for growth amid rare disease focus - Investing.com
Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024? - Yahoo Finance
Insmed Incorporated (NASDAQ:INSM) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Hsbc Holdings PLC Increases Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Long Focus Capital Management LLC Buys 309,251 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Envestnet Asset Management Inc. Purchases 119,214 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Is Insmed Inc. (INSM) the Best Performing Stock in 2024? - Yahoo Finance
Fred Alger Management LLC Makes New Investment in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
An Analysis of Indie Semiconductor Inc (INDI)’s Potential Price Growth - Knox Daily
NARI’s latest rating updates from top analysts. - Knox Daily
Intuitive Surgical Stock Is Too Hot To Touch (NASDAQ:ISRG) - Seeking Alpha
Long Term Trading Analysis for (INSG) - Stock Traders Daily
Samlyn Capital LLC Sells 228,380 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World
Recent Insider Activity Could Benefit Intuitive Surgical Inc (ISRG) - Knox Daily
Does Insmed Inc (INSM) offer a good opportunity for investors? - SETE News
Stock Market Recap: Indie Semiconductor Inc (INDI) Concludes at 3.58, a -1.38 Surge/Decline - The Dwinnex
DRW Securities LLC Invests $428,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
How should investors view Indie Semiconductor Inc (INDI)? - US Post News
Seven Eight Capital LP Sells 17,969 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
Ratio Analysis: Unpacking InMed Pharmaceuticals Inc (INM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
EverSource Wealth Advisors LLC Acquires 281 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Charting the Course: InMed Pharmaceuticals Inc’s INM Stock Prospects - The InvestChronicle
Ingredion Incorporated (NYSE:INGR) Shares Acquired by Mercer Global Advisors Inc. ADV - Defense World
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Acquires 25,714 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - MarketBeat
Does Inspire Medical Systems Inc (INSP) offer a good opportunity for investors? - SETE News
Intech Investment Management LLC Acquires Shares of 17,882 Ingredion Incorporated (NYSE:INGR) - Defense World
AE Wealth Management LLC Buys 752 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Steel Grove Capital Advisors LLC Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
First Light Asset Management LLC Has $36.94 Million Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns (NASDAQ:ISRG) - Seeking Alpha
The Globe and Mail - The Globe and Mail
Xponance Inc. Has $36.12 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Insteel Industries (NASDAQ:IIIN) Sees Strong Trading Volume - MarketBeat
Innodata Target of Unusually Large Options Trading (NASDAQ:INOD) - Defense World
Investor’s Delight: Innodata Inc (INOD) Closes Weak at 13.95, Down -2.52 - The Dwinnex
INSP’s latest rating updates from top analysts. - Knox Daily
Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Morse Asset Management Inc - Defense World
Taking a Closer Look At Immersion Corp (IMMR) Following Its Recent Trade - Knox Daily
FDA grants IND clearance for Innate Pharma’s solid tumour trial - Clinical Trials Arena
Fidelis Capital Partners LLC Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Innate Pharma Advances Novel Cancer Treatment - TipRanks
InMode (INMD): Among the Worst Middle East and Africa Stocks to Buy Now - Yahoo Finance
Tri Locum Partners LP Makes New Investment in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Innate Pharma: green light from the FDA for a study - Marketscreener.com
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - MarketBeat
Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors - StockTitan
673 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Kowal Investment Group LLC - Defense World
1832 Asset Management L.P. Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
ProShare Advisors LLC Sells 35,186 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Itau Unibanco Holding S.A. Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Insmed Inc Stock (INSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):